Jonathan-Leder

JONATHAN LEDER, PH.D.

CHAIR, CONCENTRIC SCIENTIFIC ADVISORY BOARD
RETIRED DIRECTOR, NOVOZYMES BIOLOGICALS, INC.

Dr. Jonathan Leder is a recently retired Director of Novozymes Biologicals and a 40-year scientist in the fields of organic synthesis, applied microbiology, fermentation science, and mergers and acquisitions.

Prior to his leadership role at Novozymes Biologicals, Dr. Leder worked as a scientist and Business Technology Manager at Union Carbide for 16 years. He has numerous publications and 13 patents, and has been on the scientific advisory boards of the Virginia Tech Biological Systems Engineering Department and the Science Museum of Southwest Virginia.

He earned his doctorate in organic chemistry from Harvard University.

Mark-Adams copy 2

MARK ADAMS, PH.D.

DIRECTOR OF MICROBIAL GENOMIC SERVICES
THE JACKSON LABORATORY FOR GENOMIC MEDICINE

Dr. Mark Adams is Director of Microbial Genomic Services at The Jackson Laboratory for Genomic Medicine. He has extensive experience applying genomic and bioinformatics approaches to a variety of research problems.

Prior to his position at The Jackson Laboratory, he was Scientific Director and Professor at J. Craig Venter Institute, Associate Professor of Genetics at Case Western Reserve University, a co-founder of Celera Genomics and a founding scientist at The Institute for Genomic Research, where he contributed to the first genome sequence of a free-living organism, Haemophilus influenzae.

He earned his doctorate in biological chemistry at the University of Michigan and a Bachelor of Arts in Chemistry from Warren Wilson College in North Carolina.

Gregg Bogosian2

GREGG BOGOSIAN, PH.D.

MANAGING MEMBER
GREGG BOGOSIAN, LLC

Dr. Gregg Bogosian has broad and deep experience with fermentation-based processes for manufacturing a wide variety of products, including living microorganisms, immobilized cell catalysts, proteins and enzymes, nucleic acids and small molecules including biofuels.  He is an expert in the biochemistry, genetics, physiology, genomics, and natural history and ecology of microorganisms.

As Managing Member of a consulting company, he works with numerous firms ranging from very early-stage start-ups to large multinational companies.  He also serves on the board of directors, or advisory boards, or as chief scientist of several companies.  He was a board member of Benson-Hill Biosystems from 2013-2015 and was Chief Scientist at NewLeaf Symbiotics, Inc. from 2011-2016.

Dr. Bogosian also has extensive experience in the patent arena. He is the sole or lead inventor on over 30 issued patents and pending patents.

Prior to taking an early retirement from Monsanto Company in late 2011, he served in a variety of roles during his 26 years with that company.  As a Senior Fellow, he worked as a player-coach in a close-knit research team whose accomplishments included the successful launch of Posilac, the world’s number one dairy veterinary drug.

Dr. Bogosian was a Post-Doctoral Fellow in Microbiology and Immunology at the University of North Carolina. He earned a doctorate in biochemistry from Purdue University and a Bachelor of Arts in Zoology from Miami University of Ohio.

Birgit-Scharf copy 3

BIRGIT SCHARF, PH.D.

ASSOCIATE PROFESSOR, DEPARTMENT OF BIOLOGICAL SCIENCES
VIRGINIA TECH

Dr. Birgit Scharf is an associate professor in the Department of Biological Sciences at Virginia Tech. Using genetic and biotechnological approaches, she studies how bacteria sense and move towards plants in the soil.

Dr. Scharf has had an esteemed career in academia, holding appointments at Harvard University, University of Regensburg (Germany) and the Max Planck Institute of Molecular Physiology (Germany). She has numerous publications in various molecular biology, microbiology and bacteriology journals.

She holds a doctorate in biology from Max Planck Institute of Molecular Physiology and completed postdoctoral studies there and at Harvard University. She received a diploma in biology from Ruhr-University Bochum, Germany.